Sysmex Corp

120.75-3.0600-2.47%Vol 2.50K1Y Perf -2.81%
Dec 3rd, 2021 10:24
BID0.0000 ASK0.0000
Open120.75 Previous Close123.81
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     47.27
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★★+     48.11
Price Range Ratio 52W %
62.32 
Earnings Rating
Market Cap- 
Earnings Date
-
Alpha0.02 Standard Deviation0.11
Beta0.10 

Today's Price Range

120.75120.75

52W Range

94.950136.35

5 Year PE Ratio Range

25.30083.100

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-2.47%
1 Month
-4.47%
3 Months
-5.99%
6 Months
19.44%
1 Year
-2.81%
3 Years
134.01%
5 Years
121.07%
10 Years
0.00%

TickerPriceChg.Chg.%
SSMXF120.75-3.0600-2.47
AAPL175.083.90002.28
GOOG2 974.4113.68000.46
MSFT334.970.05000.01
XOM62.450.18000.29
WFC49.41-0.8400-1.67
JNJ164.340.98000.60
FB330.567.75002.40
GE98.280.73000.75
JPM160.71-1.8600-1.14
Financial StrengthValueIndustryS&P 500US Markets
0.90
2.70
0.05
0.06
71.80
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
51.70
18.40
26.30
18.40
12.53
RevenueValueIndustryS&P 500US Markets
2.99B
14.27
-
-
DividendsValueIndustryS&P 500US Markets
1.01
0.65
30.18
9.39
Payout ratio45.00
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2.50K
Shares Outstanding0
Shares Float209.10M
Trades Count1
Dollar Volume307.91K
Avg. Volume1.29K
Avg. Weekly Volume940
Avg. Monthly Volume1.16K
Avg. Quarterly Volume1.41K
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Sysmex Corp

Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

CEO:

Telephone: +81 782650500

Address: 1-5-1 Wakinohara-Kaigandori, Kobe 6510073, , JPN

Number of employees: 8 641

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

57%43%

Bearish Bullish

27%73%

News